BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22384141)

  • 1. MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors.
    Jiao LR; Frampton AE; Jacob J; Pellegrino L; Krell J; Giamas G; Tsim N; Vlavianos P; Cohen P; Ahmad R; Keller A; Habib NA; Stebbing J; Castellano L
    PLoS One; 2012; 7(2):e32068. PubMed ID: 22384141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma.
    Felix TF; Lopez Lapa RM; de Carvalho M; Bertoni N; Tokar T; Oliveira RA; M Rodrigues MA; Hasimoto CN; Oliveira WK; Pelafsky L; Spadella CT; Llanos JC; F Silva G; Lam WL; Rogatto SR; Amorim LS; Drigo SA; Carvalho RF; Reis PP
    PLoS One; 2019; 14(5):e0217421. PubMed ID: 31150430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B.
    Liffers ST; Munding JB; Vogt M; Kuhlmann JD; Verdoodt B; Nambiar S; Maghnouj A; Mirmohammadsadegh A; Hahn SA; Tannapfel A
    Lab Invest; 2011 Oct; 91(10):1472-9. PubMed ID: 21709669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma.
    Jamieson NB; Morran DC; Morton JP; Ali A; Dickson EJ; Carter CR; Sansom OJ; Evans TR; McKay CJ; Oien KA
    Clin Cancer Res; 2012 Jan; 18(2):534-45. PubMed ID: 22114136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
    Xie F; Li C; Zhang X; Peng W; Wen T
    Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma.
    Dang Z; Xu WH; Lu P; Wu N; Liu J; Ruan B; Zhou L; Song WJ; Dou KF
    Int J Biol Sci; 2014; 10(7):733-45. PubMed ID: 25013381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNAs are Unlikely to be Involved in Retinoid Receptor Gene Regulation in Pancreatic Cancer Cells.
    Yin S; Bleul T; Zhu Y; Isayev O; Werner J; Bazhin AV
    Cell Physiol Biochem; 2017; 44(2):644-656. PubMed ID: 29169171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulation of the MiR-193b-KRAS Axis Contributes to Impaired Cell Growth in Pancreatic Cancer.
    Jin X; Sun Y; Yang H; Li J; Yu S; Chang X; Lu Z; Chen J
    PLoS One; 2015; 10(4):e0125515. PubMed ID: 25905463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells.
    Kent OA; Mullendore M; Wentzel EA; López-Romero P; Tan AC; Alvarez H; West K; Ochs MF; Hidalgo M; Arking DE; Maitra A; Mendell JT
    Cancer Biol Ther; 2009 Nov; 8(21):2013-24. PubMed ID: 20037478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1.
    Ta N; Huang X; Zheng K; Zhang Y; Gao Y; Deng L; Zhang B; Jiang H; Zheng J
    Cell Physiol Biochem; 2018; 51(2):711-728. PubMed ID: 30463064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis.
    Tanaka M; Suzuki HI; Shibahara J; Kunita A; Isagawa T; Yoshimi A; Kurokawa M; Miyazono K; Aburatani H; Ishikawa S; Fukayama M
    Oncogene; 2014 May; 33(19):2454-63. PubMed ID: 23752186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.
    Li L; Li Z; Kong X; Xie D; Jia Z; Jiang W; Cui J; Du Y; Wei D; Huang S; Xie K
    Gastroenterology; 2014 Aug; 147(2):485-97.e18. PubMed ID: 24859161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs of the mir-17~92 cluster regulate multiple aspects of pancreatic tumor development and progression.
    Quattrochi B; Gulvady A; Driscoll DR; Sano M; Klimstra DS; Turner CE; Lewis BC
    Oncotarget; 2017 May; 8(22):35902-35918. PubMed ID: 28415794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis.
    Ge W; Goga A; He Y; Silva PN; Hirt CK; Herrmanns K; Guccini I; Godbersen S; Schwank G; Stoffel M
    Gastroenterology; 2022 Jan; 162(1):269-284. PubMed ID: 34547282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.
    Zhao WG; Yu SN; Lu ZH; Ma YH; Gu YM; Chen J
    Carcinogenesis; 2010 Oct; 31(10):1726-33. PubMed ID: 20675343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene.
    Tanic M; Yanowsky K; Rodriguez-Antona C; Andrés R; Márquez-Rodas I; Osorio A; Benitez J; Martinez-Delgado B
    PLoS One; 2012; 7(6):e38847. PubMed ID: 22701724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
    He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
    Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis.
    Shimomura H; Okada R; Tanaka T; Hozaka Y; Wada M; Moriya S; Idichi T; Kita Y; Kurahara H; Ohtsuka T; Seki N
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells.
    Dong Q; Li C; Che X; Qu J; Fan Y; Li X; Li Y; Wang Q; Liu Y; Yang X; Qu X
    Oncotarget; 2016 Dec; 7(50):82338-82353. PubMed ID: 27494897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.